Previous Article | Next Article ![]()
Journal of Virology, June 2001, p. 5672-5676, Vol. 75, No. 12
Division of Viral Pathogenesis, Department of
Medicine,1 and Department of
Neurology,2 Beth Israel Deaconess Medical
Center, Harvard Medical School, Boston, Massachusetts 02215
Received 19 December 2000/Accepted 12 March 2001
JC virus (JCV), the causative agent of progressive multifocal
leukoencephalopathy (PML), has a hypervariable regulatory region (JCV
RR). A conserved archetype form is found in the urines of healthy and
immunocompromised individuals, whereas forms with tandem repeats and
deletions are found in the brains of PML patients. Type I JCV RR, seen
in MAD-1, the first sequenced strain of JCV, contains two 98-bp tandem
repeats each containing a TATA box. Type II JCV RR has additional 23-bp
and 66-bp inserts or fragments thereof and only one TATA box. We cloned
and sequenced JCV RR from different anatomic compartments of PML
patients and controls and correlated our findings with the patients'
clinical outcome. Twenty-three different sequences were defined in 198 clones obtained from 16 patients. All 104 clones with tandem repeats
were type II JCV RR. Patients with poor clinical outcome had high
proportions of JCV RR clones with both tandem repeats in plasma (54%)
and brain or cerebrospinal fluid (85%). In those who became survivors of PML, archetype sequences predominated in these anatomic compartments (75 and 100%, respectively). In patients with advanced human
immunodeficiency virus infection without PML, only 8% of JCV RR clones
obtained in the plasma contained tandem repeats. These data suggest
that the presence of tandem repeats in plasma and CNS JCV RR clones is
associated with poor clinical outcome in patients with PML.
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.12.5672-5676.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
JC Virus Regulatory Region Tandem Repeats in Plasma
and Central Nervous System Isolates Correlate with Poor Clinical
Outcome in Patients with Progressive Multifocal
Leukoencephalopathy
*
Corresponding author. Mailing address: Department of
Neurology, Beth Israel Deaconess Medical Center, RE-213, 330 Brookline Ave., Boston, MA 02215. Phone: (617) 667-1568. Fax: (617) 667-8210. E-mail: ikoralni{at}caregroup.harvard.edu.
This article has been cited by other articles:
Copyright © 2010 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»